Literature DB >> 29706458

Psychological and functional effect of different primary treatments for prostate cancer: A comparative prospective analysis.

Alessandro Sciarra1, Alessandro Gentilucci1, Stefano Salciccia1, Magnus Von Heland1, Giam Piero Ricciuti1, Vittorio Marzio1, Federico Pierella1, Daniela Musio2, Vincenzo Tombolini2, Viviana Frantellizzi3, Massimo Pasquini4, Annalisa Maraone4, Alessio Guandalini5, Martina Maggi6.   

Abstract

OBJECTIVES: The aim of the study was to comparatively evaluate the psychological and functional effect of different primary treatments in patients with prostate cancer. METHODS AND MATERIALS: We conducted a single-center prospective non randomized study in a real-life setting using functional and psychological questionnaires in prostate cancer cases submitted to radical prostatectomy, external radiotherapy, or active surveillance. Totally, 220 cases were evaluated at baseline and during the follow-up at 1-, 3-, 6-, and 12-month interval after therapy. Patients self-completed questionnaires on urinary symptoms and incontinence, erectile and bowel function, psychological distress (PD), anxiety, and depression.
RESULTS: Several significant differences among the three groups of treatment were found regarding the total score of the functional questionnaires. Regarding PD, cases submitted to radical prostatectomy showed stable scores during all the 12 months of follow-up whereas cases submitted to radiotherapy showed a rapid significant worsening of scores at 1-month interval and persistent also at 6- and 12-month interval. Cases submitted to active surveillance showed a slight and slow worsening of scores only at 12-month interval. PD and depression resulted to be more associated with urinary symptoms than sexual function worsening whereas anxiety resulted to be associated either with urinary symptoms or sexual function worsening.
CONCLUSIONS: The results of our comparative and prospective analysis could be used to better inform treatment decision-making. Patients and their teams might wish to know how functional and psychological aspects may differently be influenced by treatment choice.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Active surveillance; Prostate neoplasm; Psychological distress; Radical prostatectomy; Radiotherapy

Mesh:

Year:  2018        PMID: 29706458     DOI: 10.1016/j.urolonc.2018.03.022

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  9 in total

1.  A National Multicenter Study on overall survival in elderly metastatic castrate-resistant prostate cancer patients treated with Radium-223.

Authors:  Viviana Frantellizzi; Fabio Monari; Manlio Mascia; Renato Costa; Giuseppe Rubini; Angela Spanu; Alessio Farcomeni; Elisa Lodi Rizzini; Luca Cindolo; Alessandra Murabito; Valentina Lavelli; Susanna Nuvoli; Laura Cosma; Valeria Dionisi; Anna Giulia Nappi; Marco Andreola; Giuseppe De Vincentis
Journal:  Aging Clin Exp Res       Date:  2020-05-01       Impact factor: 3.636

2.  Mood outcomes of a behavioral treatment for urinary incontinence in prostate cancer survivors.

Authors:  Amy Y Zhang; Stephen Ganocy; Alex Z Fu; Denise Kresevic; Lee Ponsky; Gerald Strauss; Donald R Bodner; Hui Zhu
Journal:  Support Care Cancer       Date:  2019-03-22       Impact factor: 3.603

3.  The Effect of Pre-operative Psychological Interventions on Psychological, Physiological, and Immunological Indices in Oncology Patients: A Scoping Review.

Authors:  Tsipi Hanalis-Miller; Gabriel Nudelman; Shamgar Ben-Eliyahu; Rebecca Jacoby
Journal:  Front Psychol       Date:  2022-04-14

Review 4.  Cognitive and Psychological Impacts of Different Treatment Options for Prostate Cancer: A Critical Analysis.

Authors:  Konstantina G Yiannopoulou; Aikaterini I Anastasiou; Konstantinos Kontoangelos; Charalambos Papageorgiou; Ioannis P Anastasiou
Journal:  Curr Urol       Date:  2020-12-18

5.  Increased Plasmatic Levels of PSA-Expressing Exosomes Distinguish Prostate Cancer Patients from Benign Prostatic Hyperplasia: A Prospective Study.

Authors:  Mariantonia Logozzi; Daniela F Angelini; Alessandro Giuliani; Davide Mizzoni; Rossella Di Raimo; Martina Maggi; Alessandro Gentilucci; Vittorio Marzio; Stefano Salciccia; Giovanna Borsellino; Luca Battistini; Alessandro Sciarra; Stefano Fais
Journal:  Cancers (Basel)       Date:  2019-09-27       Impact factor: 6.639

6.  Analysis of Unusual Adverse Effects After Radium-223 Dichloride Administration.

Authors:  Viviana Frantellizzi; Mariano Pontico; Arianna Pani; Roberto Pani; Giuseppe De Vincentis
Journal:  Curr Radiopharm       Date:  2020

7.  Influence of operative time and blood loss on surgical margins and functional outcomes for laparoscopic versus robotic-assisted radical prostatectomy: a prospective analysis.

Authors:  Stefano Salciccia; Davide Rosati; Pietro Viscuso; Vittorio Canale; Emiliano Scarrone; Marco Frisenda; Roberta Catuzzi; Martina Moriconi; Vincenzo Asero; Stefano Signore; Mauro De Dominicis; Paolo Emiliozzi; Antonio Carbone; Antonio Luigi Pastore; Andrea Fuschi; Giovanni Battista Di Pierro; Alessandro Gentilucci; Susanna Cattarino; Gianna Mariotti; Gian Maria Busetto; Matteo Ferro; Ettore De Berardinis; Gian Piero Ricciuti; Valeria Panebianco; Fabio Massimo Magliocca; Francesco Del Giudice; Martina Maggi; Alessandro Sciarra
Journal:  Cent European J Urol       Date:  2021-11-29

Review 8.  Elective procedures for prostate cancer in the time of Covid-19: a multidisciplinary team experience.

Authors:  Alessandro Sciarra; Stefano Salciccia; Martina Maggi; Francesco Del Giudice; Gian Maria Busetto; Daniela Musio; Antonio Ciardi; Carlo Catalano; Enrico Cortesi; Valeria Panebianco
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-05-18       Impact factor: 5.455

9.  Validation of the 3-variable prognostic score (3-PS) in mCRPC patients treated with 223Radium-dichloride: a national multicenter study.

Authors:  Viviana Frantellizzi; Fabio Monari; Manlio Mascia; Renato Costa; Giuseppe Rubini; Angela Spanu; Arianna Di Rocco; Elisa Lodi Rizzini; Luca Cindolo; Maria Licari; Valentina Lavelli; Susanna Nuvoli; Cristina De Angelis; Valeria Dionisi; Cristina Ferrari; Giuseppe De Vincentis
Journal:  Ann Nucl Med       Date:  2020-07-11       Impact factor: 2.668

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.